Vaccine Efficacy Articles & Analysis
35 news found
In an epidemic, better knowledge can lead to wiser policy and can save lives. Can wastewater-based measurements of SARS-CoV-2 activity help us understand the effects of COVID-19 vaccination, and how those effects might change with new variants like Delta? To understand how wastewater can help us better understand the role of vaccines during this Delta wave, we should first look back to how we ...
Utilizing system biology approaches, adjuvant, mRNA, and vector-based technologies, Protheragen provides mRNA vaccine, DNA vaccine, live-attenuated vaccine, virus-like particle vaccine, protein subunit vaccine, and many other custom vaccines. Protheragen’s vaccine ...
These mouse models can facilitate comprehensive research into the pathogenesis, immune response, and efficacy of antiviral treatments against influenza A infections. Influenza A viruses are members of the Orthomyxoviridae family with a unique genome consisting of eight single-stranded negative-sense RNA fragments. ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine development and bioprocess applications. Vaccine development involves a variety of assays to support vaccine research and development, from early ...
This commitment to excellence in production is vital for the successful deployment of mRNA vaccines on a large scale. mRNA Vaccine Optimization Moreover, Alfa Chemistry recognizes the significance of optimization to enhance the efficacy and stability of mRNA vaccines. ...
Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) to evaluate efficacy of the company’s single-dose chikungunya virus virus-like particle (CHIKV VLP) vaccine candidate. ...
Creative Diagnostics also offers a portfolio of vaccine R&D reagents, including over 40 native antigens of key infectious pathogens, such as Corynebacterium diphtheriae, Clostridium tetani, enterovirus, hepatitis virus, influenza virus, poliovirus, rotavirus, Streptococcus pneumoniae, and Zika virus. These antigens can be used for a variety of applications, from the ...
– AUG. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and Phase 2 clinical trials investigating its anti-SARS-CoV-2 vaccine candidate AV-COVID-19 that is made at point-of-care by third-party personnel. ...
“For us, as a full voting member of T1DC, this is not only an important opportunity to be at the forefront of a changing regulatory landscape, but our contribution of data from previous trials also underlines the robustness of the evidence underpinning the safety and efficacy of our diabetes vaccine,” said Ulf Hannelius, President and CEO of Diamyd ...
Researchers running the University of Oxford-led Com-COV programme have launched a further national study assessing different options for a (third dose) booster vaccination for young people aged 12 to 15. Backed through funding from the Vaccines Taskforce and National Institute for Health Research (NIHR), the Com-COV 3 trial will seek to recruit 270 volunteers ...
This CEPI-supported trial will generate additional evidence to inform booster strategies in people previously vaccinated with vaccines distributed through COVAX, including against variants of ...
ByVaxxinit
The analysis found that participants receiving a booster dose saw a significant increase in neutralizing titers, an important predictor of vaccine efficacy. “As the COVID-19 virus continues to evolve, so does our understanding of the efficacy of vaccines and the critical role they play in protecting people from serious ...
A vaccine utilizing the POP BIO technology, EuCorVac-19, is currently in Phase II clinical studies through an ongoing collaboration and licensing arrangement between POP BIO and the Korean vaccine maker Eubiologics, Co. ...
What sets our test apart is that it uses YourBio Health’s innovative blood collection device, that is both convenient and nearly painless.” While COVID-19 vaccines are highly effective, some studies have suggested not all people retain vaccine antibodies for longer than a few weeks or months – potentially leaving them unknowingly at higher ...
"COVID-19 variants can be more transmissible and potentially impact efficacy of diagnostics, vaccines and therapies, threatening to reverse progress made in the past year," said Manoj Gandhi, M.D., Ph.D., senior medical director, genetic sciences for Thermo Fisher. ...
Predictions of which influenza strains will be circulating each year are made more than six months before the onset of flu season—and even if projections are accurate, unexpected strains can and do arise, rendering that year’s vaccine minimally effective. The best-case scenario results in delivery of seasonal flu vaccines with an average 30%–60% ...
(Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial called Comparing COVID-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2), to be conducted by the University of Oxford and supported by the UK ...
ByNovavax
Published online in Preprints with The Lancet, this vaccine's high levels of protective efficacy hold promise of becoming an important tool for global malaria eradication. ...
ByNovavax
The OTC testing options are not covered by insurance and are not meant to diagnose acute COVID-19 infection or test the efficacy of COVID-19 vaccination. CVS Health has been increasing access to testing options since the start of the pandemic and has completed more than 15 million COVID-19 tests to date across more than 4,800 testing sites at select CVS Pharmacy ...
The COVID-19 pandemic has highlighted the need to accelerate the development and validation of new vaccine technologies and methods such as the ones described above, and the accumulating safety and efficacy data resulting from their continued use will be helpful in determining their ongoing utility. The future of vaccines is bright, and the ...